Innospec Q2 2022 revenue up 32% to $467.6M; adjusted EPS $1.58 vs $1.30 last year

INNOSPEC INC.

2022-Q2 EPS reported $2.76 revenue$940,000,000

GAAP EPS of $1.29 ($32.3M net income) versus $0.90 in Q2 2021.
Adjusted non-GAAP EPS of $1.58; revenue $467.6M, up 32% YoY.
EBITDA of $52.9M compared to $50.6M a year ago.
Cash used in operations $7.5M due to working capital increase; net cash $71.4M at quarter end.
Repurchased 18,700 shares for $1.8M; plans for further Performance Chemicals capacity expansion.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.